BoostIron™ - prevents iron deficiency anemia
BoostIron™ - References
|I Product Info||I Ingredients||I Recommended Use||I Clinical Trials||I Research Brief||I References|
Indication: iron deficiency anemia prevention.
Main Actions: prevents iron deficiency anemia, a source of carbonyl iron and vitamins for better absorption, strengthens body’s immune system, essential for the growing organism, during pregnancy, in postoperative period.
Ingredients (per 1 tablet): iron (as carbonyl iron) - 10 mg, vitamin C (as ascorbic acid) – 70 mg, folate (as folic acid) – 200 mcg, vitamin B12 (as cyanocobalamin) – 3 mcg.
Low USA domestic & international
BoostIron™ - References:
1. CDC Recommendations to prevent and control iron deficiency in the United States. Centers for Disease Control and Prevention. MMWR Recomm Rep 1998;47:1-29.
2. Stoltzfus RJ. Defining iron-deficiency anemia in public health terms: reexamining the nature and magnitude of the public health problem. J Nutr 2001;131:565S-7S.
3. Hallberg L. Prevention of iron deficiency. Baillieres Clin Haematol 1994;7:805-14.
4. Pollitt E. Poverty and child development: relevance of research in developing countries to the United States. Child Dev 1994;65(2 Spec No):283-95.
5. Hurtado EK, Claussen AH, Scott KG. Early childhood anemia and mild or moderate mental retardation. Am J Clin Nutr 1999;69:115-9.
6. Roncagliolo M, Garrido M, Walter T, et al. Evidence of altered central nervous system development in infants with iron deficiency anemia at 6 mo: delayed maturation of auditory brainstem responses. Am J Clin Nutr 1998;68:683-90.
7. Williams J, Wolff A, Daly A, et al. Iron supplemented formula milk related to reduction in psychomotor decline in infants from inner city areas: randomised study. BMJ 1999;318:693
8. Dallman PR. Iron deficiency and the immune response. Am J Clin Nutr. 1987; 46:329-334.
9. Gordeuk VR, Brittenham GM, Bravo J, Hughes MA, Keating LJ. Department of Medicine, Cleveland Metropolitan General Hospital, Ohio.